NISAN - The National Institute for Stroke and Applied Neurosciences

NISAN
AUT NISAN
AUT Main Nav
Centre Banner
Main Content

The National Institute for Stroke and Applied Neurosciences

The National Institute for Stroke and Applied Neurosciences (NISAN) conducts epidemiological studies and clinical trials to improve health and outcomes in people with major neurological disorders. Current research programmes focus on:

  • Stroke
  • Traumatic brain injury
  • Neuromuscular disorders


Research with this aim is unique in New Zealand and NISAN is a hub for information sharing and developing a cohesive network between existing research and clinical groups with interests in:

  • Neuroepidemiology
  • Public health
  • Neurorehabilitation
  • Neuropsychology
  • Biostatistics

Recent developments

Currently available cardiovascular disease (CVD) risk assessment algorithms allow calculation of absolute risk of CVD (including stroke) but they are designed for use by health professionals and require a lab test to complete. For an individual, one of the main challenges in effective stroke prevention is:

  • Lack of awareness about stroke symptoms and risk factors
  • Self-managing strategies to reduce their risk of stroke

We have developed an App called Stroke Riskometer which has the potential to:

  • Significantly improve stroke prevention in individuals with an increased CVD risk.

The Stroke Riskometer calculates your risk by evaluating a series of risk factors such as age, gender, ethnicity, lifestyle and other health factors that directly influence your likelihood of a stroke within the next 5 and 10 years, and the user can:

  • Find out their risk of developing a stroke
  • Have a baseline risk to compare their risk against
  • Compare details with someone of their age and sex who has no risk factors.

Developed in collaboration with international leaders in stroke prevention, The Stroke Riskometerâ„¢ app:

  • Is an award winning and easy-to-use tool
  • Measures your individual risk of a stroke in the next 5 to 10 years
  • The Pro version provides essential information on how to reduce the chance of stroke.

Reducing the International Burden of Stroke Using Mobile Technology (RiBURST), is a worldwide study conducting cross-sectional, cohort and interventional (primary prevention) research of stroke and other major non-communicable diseases (NCD) (heart attack, dementia and type 2 diabetes mellitus).

You can help us learn more by:


  • Submitting your data to help us better understand stroke, its risk factors and develop global prevention strategies.

The information presented in the Stroke Riskometer has been developed by Professor Valery Feigin (MD, MSc, PhD, FAAN), Director of the National Institute for Stroke and Applied Neurosciences, AUT, New Zealand.



Last updated: 09 Jul 2014 2:05pm

Auckland University of Technology, New Zealand | Copyright © | Privacy | Site map

AUT News Area
Apr 23rd, 2015

NZANC Conference

The New Zealand Applied Neurosciences Conference is held in Auckland, New Zealand.  The next conference will be in September 2016.  Watch this space for more information.


Feigin, V.L., Krishnamurthi, et al on behalf of the Global Burden of Diseases, Injuries, and Risk Factors Study (the GBD 2010 Study) and the GBD Stroke Experts Group* Global and regional burden of stroke in 1990-2010:  incidence, mortality, prevalence, and disability-adjusted life-years lost. The Lancet 2013.
Dec 16th, 2014

Braden Te Ao
Area of expertise: Health Services Research and Health Economics
Qualification: MPH (hons), PGDip PH, BHSc. PhD Student.